Latest

  • Clinical Research

    FDA Drug Amendments: Still a good fit at fifty?

    By Laura Stark Fifty years ago on Wednesday, President Kennedy signed into law the US Food and Drug Amendments. The amendments radically overhauled the way in which manufacturers brought drugs to market. Most importantly, the…

    FDA Drug Amendments: Still a good fit at fifty?

  • Bioethics

    Upcoming Event – Frank Miller on Placebo-Controlled Trials Before Informed Consent

    By The Petrie-Flom Center What were they thinking? Placebo-controlled trials before informed consent Franklin G. Miller, Ph.D., Department of Bioethics, National Institutes of Health October 25, 2012 – 4pm Shapiro Clinical Center JCRT 5A (East Campus), Beth Israel Deaconess Medical Center, Boston, MA Sponsored by the Program in…

    Upcoming Event – Frank Miller on Placebo-Controlled Trials Before Informed Consent

  • Bioethics

    Art Caplan on Grace Lee

    By Arthur Caplan Unfortunately, these stories are like deja vu.  In his most recent MSNBC commentary, Art Caplan emphasizes that we all have the right to refuse medical care, even if others disagree and even…

    Art Caplan on Grace Lee

  • Bioethics

    Incentives for Blood Donation

    Al Roth has an interesting post up today at his Market Design blog referencing some data on the crowding out effect, i.e., the idea that if you pay people for something that they are currently…

    Incentives for Blood Donation

  • Bioethics

    What Is a (Big) Bird in the Hand Worth?

    by Suzanne M. Rivera, Ph.D. The Presidential debate on Wednesday was fascinating theater.  Much of the post-debate commentary in social media has focused on Mitt Romney’s threat to cut federal funding to PBS as a…

    What Is a (Big) Bird in the Hand Worth?

  • End-of-Life

    Upcoming Event: Harvard Med School Public Forum

    PRESCRIBING MEDICATION TO END LIFE THURSDAY, OCTOBER 25, 2012 4:00 – 6:00 PM Harvard Medical School Carl W. Walter Amphitheater Tosteson Medical Education Center 260 Longwood Avenue, Boston Should a physician licensed in Massachusetts–at the…

    Upcoming Event: Harvard Med School Public Forum

  • Biotechnology

    FDA’s New Dance with Big Pharma: Are Patients the Band?

    By Efthimios Parasidis One week prior to the Supreme Court’s landmark ruling in the health care cases, Democrats and Republicans overwhelmingly voted in favor of health-related legislation (387-5 House; 96-1 Senate).  Industry and HHS were quick…

    FDA’s New Dance with Big Pharma: Are Patients the Band?